The European Parliament’s approval of instant payments has significant implications for corporates across the continent. This move towards faster and...
Clinical trials play a crucial role in advancing medical knowledge and improving patient care. They are essential for testing new...
The Clean Fuel Standard Successfully Approved by New Mexico Legislature In a significant move towards combating climate change and reducing...
The Central Drugs Standard Control Organization (CDSCO) in India has recently released regulatory guidelines for the sampling of medical devices,...
FDA Approves First Cell Therapy for Solid Tumors, Marking a Significant Milestone In a groundbreaking development, the U.S. Food and...
The Inflation Reduction Act for Clinical Research Professionals (ACRP) is a significant piece of legislation that aims to address the...
The Food and Drug Administration (FDA) has recently approved the expanded use of Xolair, a medication primarily used for treating...
A Comprehensive Guide to MDCG’s Clinical Investigations: Part 2 in the EU In the European Union (EU), the Medical Device...
India’s defence capabilities are set to receive a significant boost with the recent approval of the acquisition of mid-air refuelers...
Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
A Comprehensive Guide to Navigating US FDA 510(k) Approval for In Vitro Diagnostic Devices (IVDs) Introduction: In vitro diagnostic devices...
California’s Stance on License Transfers in Cannabis M&A The cannabis industry has been rapidly growing in California since the legalization...
Exploring License Transfer Possibilities: Cannabis M&A in California The cannabis industry in California has experienced significant growth since the legalization...
An In-depth Analysis of the Expensive Drug Development Process The process of developing new drugs is a complex and expensive...
Gary Gensler from the SEC Provides Clarification on Bitcoin ETF Approval, Stating it Does Not Ensure Approval for Ethereum ETF
Gary Gensler, the chairman of the U.S. Securities and Exchange Commission (SEC), recently provided some much-needed clarification on the approval...